Poland· PL-100465449
Riltrava Aerosphere
A formoterol, glycopyrronium bromid und budesonid product containing formoteroli fumaras dihydricus + glycopyrronium + budesonidum, registered in Poland by AstraZeneca AB. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Formoterol, glycopyrronium bromid und budesonid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL11 (formoterol, glycopyrronium bromid und budesonid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Formoterol, glycopyrronium bromid und budesonid · ATC R03AL11
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Formoteroli fumaras dihydricus + Glycopyrronium + Budesonidum
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- R03AL11
- ATC class
- Formoterol, Glycopyrronium bromid und Budesonid
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol, glycopyrronium bromid und budesonid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandTrixeo Aerosphere 5/7.2/160 μg, Druckgasinhalation, SuspensionAstraZeneca AG
- IcelandRiltrava AerosphereAstraZeneca AB
- NetherlandsRiltrava Aerosphere 5 microgram/7,2 microgram/160 microgram, aerosol, suspensie, suspensieAstraZeneca AB
- CanadaBREZTRI AEROSPHEREASTRAZENECA CANADA INC
- SpainTRIXEO AEROSPHERE 5 microgramos/7,2 microgramos/160 microgramos SUSPENSION PARA INHALACION EN ENVASE A PRESIONAstrazeneca Ab
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa91b81d-5fe1-465f-b14a-9bb2088bdec0 GET /v1/drugs/aa91b81d-5fe1-465f-b14a-9bb2088bdec0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol inhalacyjny, zawiesina",
"source": "urpl",
"strength": "5 mcg + 7,2 mcg + 160 mcg",
"packaging": "Rp ¦ EU/1/21/1604/001 ¦ 144147\n1 poj. 120 dawek\nRp ¦ EU/1/21/1604/002 ¦ 144148\n3 poj. 360 dawek (3 x 120)",
"substance": "Formoteroli fumaras dihydricus 5 mcg + Glycopyrronium 7.2 mcg + Budesonidum 160 mcg",
"common_name": "Formoteroli fumaras dihydricus + Glycopyrronium + Budesonidum",
"pl_product_id": "100465449",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about formoterol, glycopyrronium bromid und budesonid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.